Frederique Penault-LLorca

Frederique Penault-LLorca

UNVERIFIED PROFILE

Are you Frederique Penault-LLorca?   Register this Author

Register author
Frederique Penault-LLorca

Frederique Penault-LLorca

Publications by authors named "Frederique Penault-LLorca"

Are you Frederique Penault-LLorca?   Register this Author

100Publications

3996Reads

47Profile Views

Correlation of ROS1 Immunohistochemistry With Fusion Status Determined by Fluorescence In Situ Hybridization.

Arch Pathol Lab Med 2019 Sep 11. Epub 2019 Sep 11.

From Roche Molecular Solutions, Pleasanton, California (Dr Huang, Mr Smith, Dr Le, Mr Liu, Dr Ordinario, Dr Manohar, Mr Lee, Mr Rajamani, Mr Truong, Dr Jing Li, Ms Choi, Dr Jingchuan Li, Dr Pati, Ms Hanlon Newell, Mr Pate, and Dr Menzl); Institute of Pathology, University Hospital Basel, Basel, Switzerland (Dr Bubendorf); Institute for Pathology, University Hospital, Cologne, Germany (Dr Buettner); the Department of Pathology, Aberdeen University Medical School & Aberdeen Royal Infirmary, Foresterhill, Aberdeen, United Kingdom (Dr Kerr); Laboratorio de Dianas Terapeuticas, HM Hospitales, Spain (Dr Lopez-Rios); Center of Predictive Molecular Medicine, CeSIMeT, University of Chieti-Pescara, Italy (Dr Marchetti); Pfizer Oncology, International Developed Markets, Berlin, Germany (Ms Marondel); the Department of Histopathology, Royal Brompton and Harefield Hospitals, and National Heart and Lung Division, Imperial College, London, United Kingdom (Dr Nicholson); the Pathology Department, Istanbul University, Cerrahpassa Medical Faculty, Istanbul, Turkey (Dr Öz); CORE, Antwerp University, and the Department of Pathology, Antwerp University Hospital, Antwerp, Belgium (Mr Pauwels); the Department of Biopathology, Centre Jean Perrin & INSERM U240 IMoST and Université Clermont Auvergne, Clermont-Ferrand, France (Dr Penault-Llorca); Operative Unit of Pathology, AUSL della Romagna, Hospital S. Maria delle Croci, Ravenna, Italy (Dr Rossi); and the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2019-0085-OADOI Listing
September 2019

Breast cancer.

Nat Rev Dis Primers 2019 Sep 23;5(1):66. Epub 2019 Sep 23.

Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41572-019-0111-2DOI Listing
September 2019

Testing algorithm for identification of patients with TRK fusion cancer.

J Clin Pathol 2019 Jul 9;72(7):460-467. Epub 2019 May 9.

Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2018-205679DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589488PMC
July 2019

From Targeting Somatic Mutations to Finding Inherited Cancer Predispositions: The Other Side of the Coin.

Diagnostics (Basel) 2019 Jul 26;9(3). Epub 2019 Jul 26.

Department of pathology, Centre Jean Perrin, 63000 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/diagnostics9030083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787697PMC
July 2019

[HIPEC in ovarian cancer: What should we expect?]

Bull Cancer 2019 May 21. Epub 2019 May 21.

Centre Jean-Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551193019
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2019.04.003DOI Listing
May 2019

The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines.

J Clin Med 2019 Mar 21;8(3). Epub 2019 Mar 21.

Université Clermont Auvergne, Institut Universitaire de Technologie, INSERM, U1240, Imagerie Moléculaire et Stratégies Théranostiques, F-63000 Clermont Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8030397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463163PMC
March 2019

Tumor mutational burden in non-small cell lung cancer-the pathologist's point of view.

Transl Lung Cancer Res 2018 Dec;7(6):716-721

Department of pathology, Centre Jean Perrin, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.09.26DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249617PMC
December 2018

TIP60: an actor in acetylation of H3K4 and tumor development in breast cancer.

Epigenomics 2018 11 16;10(11):1415-1430. Epub 2018 Oct 16.

Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 Place Henri-Dunant, 63001, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/epi-2018-0004
Publisher Site
http://dx.doi.org/10.2217/epi-2018-0004DOI Listing
November 2018

Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer.

Cancers (Basel) 2018 Oct 30;10(11). Epub 2018 Oct 30.

Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers10110409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266715PMC
October 2018

Exciting History of Tip60 and Its Companions in Carcinogenesis Across the Heterochromatin Landscapes.

OMICS 2018 09 14;22(9):626-628. Epub 2018 Aug 14.

1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/omi.2018.0122DOI Listing
September 2018

High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast.

Histopathology 2018 Aug 7;73(2):273-283. Epub 2018 May 7.

Institut Curie, Paris Sciences Lettres Research University, Pôle de médecine diagnostique et théranostique, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13514DOI Listing
August 2018

SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer.

Oncotarget 2018 Jul 17;9(55):30661-30678. Epub 2018 Jul 17.

Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand 63001, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078139PMC
July 2018

A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2.

Oncotarget 2018 May 4;9(34):23413-23425. Epub 2018 May 4.

Department of Oncogenetics, Center Jean Perrin, CBRV, 63001 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955128PMC
May 2018

Development and validation of a high-performance liquid chromatography method for the quantitation of intracellular PARP inhibitor Olaparib in cancer cells.

J Pharm Biomed Anal 2018 Apr 31;152:74-80. Epub 2018 Jan 31.

Université Clermont Auvergne, Institut Universitaire de Technologie, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, F-63000 Clermont Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2018.01.036DOI Listing
April 2018

SIRT1 in Colorectal Cancer: A Friend or Foe?

OMICS 2018 04 27;22(4):298-300. Epub 2018 Mar 27.

1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/omi.2018.0006DOI Listing
April 2018

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.

BMC Cancer 2018 02 3;18(1):129. Epub 2018 Feb 3.

Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4013-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797400PMC
February 2018

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.

J Clin Oncol 2017 Dec 20;35(34):3867-3876. Epub 2017 Oct 20.

Reinhard Büttner, University Hospital Cologne, Cologne; Manfred Dietel, Charité Universitätsmedizin Berlin, Berlin, Germany; John R. Gosney, Royal Liverpool University Hospital, Liverpool; Andrew C. Wotherspoon, Royal Marsden Hospital, London; Keith M. Kerr, Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom; Birgit Guldhammer Skov, Copenhagen University Hospital, Copenhagen, Denmark; Julien Adam, Gustave Roussy Cancer Center, Villejuif; Frédérique Penault-Llorca, Jean Perrin Comprehensive Cancer Center, Clermont-Ferrand, France; Noriko Motoi, National Cancer Center Hospital, Tokyo, Japan; Kenneth J. Bloom, Human Longevity, San Diego, CA; John W. Longshore, Carolinas Pathology Group, Charlotte, NC; Fernando López-Ríos, Hospital Universitario HM Sanchinarro, Madrid, Spain; Giuseppe Viale, University of Milan, Milan, Italy; and Ming-Sound Tsao, University Health Network, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.7642DOI Listing
December 2017

EZH2 Histone Methyltransferase and JMJD3 Histone Demethylase Implications in Prostate Cancer.

OMICS 2017 12 21;21(12):751-753. Epub 2017 Nov 21.

1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/omi.2017.0106DOI Listing
December 2017

Dual SIRT1 expression patterns strongly suggests its bivalent role in human breast cancer.

Oncotarget 2017 Dec 6;8(67):110922-110930. Epub 2017 Dec 6.

Centre Jean Perrin, Department of Oncogenetics-CBRV, 63001 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.23006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762295PMC
December 2017

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:
Shona Hendry Roberto Salgado Thomas Gevaert Prudence A Russell Tom John Bibhusal Thapa Michael Christie Koen van de Vijver M V Estrada Paula I Gonzalez-Ericsson Melinda Sanders Benjamin Solomon Cinzia Solinas Gert G G M Van den Eynden Yves Allory Matthias Preusser Johannes Hainfellner Giancarlo Pruneri Andrea Vingiani Sandra Demaria Fraser Symmans Paolo Nuciforo Laura Comerma E A Thompson Sunil Lakhani Seong-Rim Kim Stuart Schnitt Cecile Colpaert Christos Sotiriou Stefan J Scherer Michail Ignatiadis Sunil Badve Robert H Pierce Giuseppe Viale Nicolas Sirtaine Frederique Penault-Llorca Tomohagu Sugie Susan Fineberg Soonmyung Paik Ashok Srinivasan Andrea Richardson Yihong Wang Ewa Chmielik Jane Brock Douglas B Johnson Justin Balko Stephan Wienert Veerle Bossuyt Stefan Michiels Nils Ternes Nicole Burchardi Stephen J Luen Peter Savas Frederick Klauschen Peter H Watson Brad H Nelson Carmen Criscitiello Sandra O'Toole Denis Larsimont Roland de Wind Giuseppe Curigliano Fabrice André Magali Lacroix-Triki Mark van de Vijver Federico Rojo Giuseppe Floris Shahinaz Bedri Joseph Sparano David Rimm Torsten Nielsen Zuzana Kos Stephen Hewitt Baljit Singh Gelareh Farshid Sibylle Loibl Kimberly H Allison Nadine Tung Sylvia Adams Karen Willard-Gallo Hugo M Horlings Leena Gandhi Andre Moreira Fred Hirsch Maria V Dieci Maria Urbanowicz Iva Brcic Konstanty Korski Fabien Gaire Hartmut Koeppen Amy Lo Jennifer Giltnane Marlon C Rebelatto Keith E Steele Jiping Zha Kenneth Emancipator Jonathan W Juco Carsten Denkert Jorge Reis-Filho Sherene Loi Stephen B Fox

Adv Anat Pathol 2017 Nov;24(6):311-335

Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638696PMC
November 2017

TIP60 Histone Acetyltransferase in Adipose Tissue: Possible Linkages with Breast Cancer Development?

OMICS 2017 11 5;21(11):684-686. Epub 2017 Sep 5.

1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/omi.2017.0117DOI Listing
November 2017

Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines.

Oncotarget 2017 11 24;8(56):95316-95331. Epub 2017 Aug 24.

Université Clermont Auvergne, Institut Universitaire de Technologie, INSERM, U1240, Imagerie Moléculaire et Stratégies Théranostiques, F-63000 Clermont Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707024PMC
November 2017

miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers.

Pathol Oncol Res 2017 Oct 18;23(4):815-827. Epub 2017 Jan 18.

Laboratory of Biochemistry Research unit UR 12ES08 Cell Signaling and Disease, Faculty of Medicine of Monastir, University of Monastir, 5019, Monastir, Tunisia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12253-017-0188-4DOI Listing
October 2017

P-gp expression levels in the erythrocytes of brown trout: a new tool for aquatic sentinel biomarker development.

Biomarkers 2017 Sep 19;22(6):566-574. Epub 2017 Jun 19.

a Université Clermont Auvergne, Institut Universitaire de Technologie de Clermont-Fd INSERM, UMR 1240 Imagerie Moléculaire et Stratégies Théranostiques , Clermont Ferrand , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1354750X.2017.1338314DOI Listing
September 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.

Authors:
Shona Hendry Roberto Salgado Thomas Gevaert Prudence A Russell Tom John Bibhusal Thapa Michael Christie Koen van de Vijver M V Estrada Paula I Gonzalez-Ericsson Melinda Sanders Benjamin Solomon Cinzia Solinas Gert G G M Van den Eynden Yves Allory Matthias Preusser Johannes Hainfellner Giancarlo Pruneri Andrea Vingiani Sandra Demaria Fraser Symmans Paolo Nuciforo Laura Comerma E A Thompson Sunil Lakhani Seong-Rim Kim Stuart Schnitt Cecile Colpaert Christos Sotiriou Stefan J Scherer Michail Ignatiadis Sunil Badve Robert H Pierce Giuseppe Viale Nicolas Sirtaine Frederique Penault-Llorca Tomohagu Sugie Susan Fineberg Soonmyung Paik Ashok Srinivasan Andrea Richardson Yihong Wang Ewa Chmielik Jane Brock Douglas B Johnson Justin Balko Stephan Wienert Veerle Bossuyt Stefan Michiels Nils Ternes Nicole Burchardi Stephen J Luen Peter Savas Frederick Klauschen Peter H Watson Brad H Nelson Carmen Criscitiello Sandra O'Toole Denis Larsimont Roland de Wind Giuseppe Curigliano Fabrice André Magali Lacroix-Triki Mark van de Vijver Federico Rojo Giuseppe Floris Shahinaz Bedri Joseph Sparano David Rimm Torsten Nielsen Zuzana Kos Stephen Hewitt Baljit Singh Gelareh Farshid Sibylle Loibl Kimberly H Allison Nadine Tung Sylvia Adams Karen Willard-Gallo Hugo M Horlings Leena Gandhi Andre Moreira Fred Hirsch Maria V Dieci Maria Urbanowicz Iva Brcic Konstanty Korski Fabien Gaire Hartmut Koeppen Amy Lo Jennifer Giltnane Marlon C Rebelatto Keith E Steele Jiping Zha Kenneth Emancipator Jonathan W Juco Carsten Denkert Jorge Reis-Filho Sherene Loi Stephen B Fox

Adv Anat Pathol 2017 Sep;24(5):235-251

Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564448PMC
September 2017

The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer.

Sci Rep 2017 07 26;7(1):6597. Epub 2017 Jul 26.

Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-06790-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529370PMC
July 2017

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.

J Natl Cancer Inst 2017 05 31;109(5). Epub 2016 Dec 31.

Affiliations of authors: Department of Gastroenterology and GI Oncology, Université Paris Descartes, Hopital Européen Georges Pompidou, Paris, France (JTai); Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France (KLM); Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (QS, DJS); Department of Pathology, Centre Jean Perrin, EA ERTICa, Université d'Auvergne, Clermont-Ferrand, France (FPL); Centre Hospitalier Universitaire Robert Debré, Reims, France (OB); Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain (JTab); Spanish Gastrointestinal Tumors TTD Group, Universitat Autònoma de Barcelona, Barcelona, Spain (JTab); Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy (EM); Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG); First Medical Department, University Hospital Carl Gustav Carus, Dresden, Germany (GF); Department of Gastroenterology, Hôpital Universitaire Erasme, Brussels, Belgium (JLVL); Department of Oncology, Mayo Clinic and Mayo Cancer Center, Rochester, MN (SRA, FAS); Pathology Department, Ambroise Paré Hospital, Boulogne, France (JFE); Université Paris Descartes, Sorbonne Paris Cité, France (PLP); Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France (PLP); INSERM UMR-S1147, Paris, France (PLP).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075212PMC
May 2017

Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study.

Clin Breast Cancer 2017 Apr 31;17(2):107-116. Epub 2016 Aug 31.

Assistance Publique Hôpitaux de Paris (AP-HP), Department of Radiation Oncology and Henri Mondor Breast Center, INSERM U955 E07, and University of Paris-Est Créteil (UPEC), France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2016.08.007DOI Listing
April 2017

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.

BMC Cancer 2017 04 12;17(1):261. Epub 2017 Apr 12.

Department of Oncogenetics, Centre Jean Perrin - CBRV, 28 place Henri Dunant, BP 38, 63001, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3256-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388998PMC
April 2017

Ki67 assessment in breast cancer: an update.

Pathology 2017 Feb 5;49(2):166-171. Epub 2017 Jan 5.

Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/Univerisity of Auvergne UMR1240, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2016.11.006DOI Listing
February 2017

[Strategies around PD-L1 testing in France].

Ann Pathol 2017 Feb 17;37(1):3-4. Epub 2017 Jan 17.

Centre Jean-Perrin, Inserm UMR 1240, 58, rue Montalembert, 63011 Clermont-Ferrand, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2016.11.003DOI Listing
February 2017

Epigenetic Modifications with DZNep, NaBu and SAHA in Luminal and Mesenchymal-like Breast Cancer Subtype Cells.

Cancer Genomics Proteomics 2016 Jul-Aug;13(4):291-303

Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France EA 4677 "ERTICA", University of Auvergne, Clermont-Ferrand, France

View Article

Download full-text PDF

Source
January 2017

[Evaluation of the immune infiltrate in breast cancer].

Bull Cancer 2017 Jan 13;104(1):52-68. Epub 2016 Dec 13.

Centre Jean Perrin, département d'anatomie et de cytologie pathologiques, 58, rue Montalembert, 63011 Clermont-Ferrand, France; Inserm U1240 « Imagerie moléculaire et stratégies théranostiques (IMoST) », 58, rue Montalembert, 63011 Clermont-Ferrand, France; Université d'Auvergne, faculté de médecine, 28, place Henri-Dunant, 63000 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.11.010DOI Listing
January 2017

High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.

Cancer Lett 2016 11 7;382(1):77-85. Epub 2016 Mar 7.

Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri-Dunant, 63001, Clermont-Ferrand, France; EA 4677 "ERTICA", University of Auvergne, 63011, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2016.03.001DOI Listing
November 2016

A bivalent role of TIP60 histone acetyl transferase in human cancer.

Epigenomics 2015 7;7(8):1351-63. Epub 2015 Dec 7.

Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 place Henri Dunant, 63001 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/epi.15.76DOI Listing
October 2016

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis.

J Pathol Clin Res 2016 Oct 13;2(4):234-246. Epub 2016 Jul 13.

ERTICA EA4677 Research Team, University of Auvergne, Faculty of Medecine28 place Henri DunantF-63001Clermont-FerrandFrance; Department of Medical CytogeneticsCHU Estaing1 place Lucie et Raymond AubracF-63003Clermont-FerrandFrance.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.52DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068194PMC
October 2016

Biomarkers of residual disease after neoadjuvant therapy for breast cancer.

Nat Rev Clin Oncol 2016 08 9;13(8):487-503. Epub 2016 Feb 9.

Department of Pathology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, BP392, 63011 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.1DOI Listing
August 2016

H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes.

Epigenomics 2016 07 18;8(7):909-24. Epub 2016 Jul 18.

Department of Oncogenetics, Centre Jean Perrin, CBRV, 28 Place Henri Dunant, 63001 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/epi-2016-0015DOI Listing
July 2016

Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen.

PLoS One 2015 2;10(10):e0138443. Epub 2015 Oct 2.

Clermont Université, Université d'Auvergne, UMR 1019, Unité de Nutrition Humaine, CRNH-Auvergne, BP 10448, F-63000, Clermont-Ferrand, France; Centre Jean Perrin, Unicancer, F-63000, Clermont-Ferrand, France; CHU Clermont-Ferrand, Unité d'exploration nutritionnelle, F-63003, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138443PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592217PMC
June 2016

[Glandular lesions of the uterine cervix: Case 7].

Ann Pathol 2016 Jun 25;36(3):204-6. Epub 2016 May 25.

Service d'anatomie pathologique, hôpital de la Croix-Rousse, 103, Grande-Rue de la Croix-Rousse, 69004 Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2016.03.002DOI Listing
June 2016

[Glandular lesions of the uterine cervix: Case 8].

Ann Pathol 2016 Jun 25;36(3):207-9. Epub 2016 May 25.

Service d'anatomie pathologique, hôpital de la Croix-Rousse, 103, Grande rue de la Croix-Rousse, 69004 Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2016.03.010DOI Listing
June 2016

Erratum to: Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue.

Breast Cancer Res Treat 2016 Apr;156(2):401-2

INSERM-UPMC Université Paris 06, UMRS 938, Hôpital Saint Antoine, 75012, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3712-4DOI Listing
April 2016

[Strategy for molecular testing in pulmonary carcinoma].

Ann Pathol 2016 Jan 8;36(1):73-9. Epub 2016 Jan 8.

Département de pathologie, centre Jean-Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2015.11.005DOI Listing
January 2016

DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition.

Am J Cancer Res 2015 15;5(7):2113-26. Epub 2015 Jun 15.

Department of Molecular Oncology, Centre Jean Perrin Clermont-Ferrand 63000, France ; Université d'Auvergne EA 4677, ERTICa, BP 10448, Clermont-Ferrand 63000, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548324PMC
September 2015

Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.

Oncologist 2015 Aug 25;20(8):873-9. Epub 2015 Jun 25.

APHP Tenon, IUC-UPMC, Sorbonne Université, Alliance Pour la Recherche en Cancérologie, Paris, France; University Hospital Jean Minjoz, UMR1098, SFR IBCT, Besançon, France; Institut du Cancer Montpellier, Université Montpellier 1, Montpellier, France; Centre Azuréen de Cancérologie, Mougins, France; Centre d'Oncologie de Gentilly, Nancy, France; APHP-St. Louis, Université Paris Diderot, Paris, France; Centre Jean-Perrin, Université d'Auvergne, Clermont-Ferrand, France; Research Unit EA 7285, University of Versailles St-Quentin, Montigny-le-Bretonneux, France; Department of Surgery, Institut Curie, Saint-Cloud, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524752PMC
August 2015

BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib.

Sci Rep 2015 Aug 3;5:12670. Epub 2015 Aug 3.

Clermont Université - Université d'Auvergne - ERTICa - EA 4677 - Institut Universitaire de Technologie, Département Génie Biologique, Ensemble universitaire des Cézeaux, B.P. 86 - 63172 AUBIERE CEDEX, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep12670DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522660PMC
August 2015

Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

Crit Rev Oncol Hematol 2015 Jul 4;95(1):88-104. Epub 2015 Mar 4.

Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.02.011DOI Listing
July 2015

French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.

Eur Respir J 2015 Jul 30;46(1):207-18. Epub 2015 Apr 30.

Département d'Anatomie et de Cytologie Pathologiques, Pôle de Biologie et de Pathologie, CHU A. Michallon, and Université Joseph Fourier, INSERM U823, Institut Albert Bonniot, Grenoble, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09031936.00119914DOI Listing
July 2015

The Role of Soy Phytoestrogens on Genetic and Epigenetic Mechanisms of Prostate Cancer.

Enzymes 2015;37:193-221. Epub 2015 Jul 23.

Department of Oncogenetics, Centre Jean Perrin-CBRV, Clermont-Ferrand, France; EA 4677 "ERTICA," University of Auvergne, Clermont-Ferrand, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.enz.2015.05.004DOI Listing
July 2015

[Commercially available genomic-based signatures in early breast cancer: Is it ready for tomorrow morning?].

Bull Cancer 2015 Jun;102(6 Suppl 1):S100-1

Département de pathologie et de biopathologie, Centre Jean-Perrin, 63011 Clermont-Ferrand cedex, France; EA 4677 Université d'Auvergne, Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(15)31226-1DOI Listing
June 2015

[Prophylactic salpingectomy or salpingo-oophorectomy as an ovarian cancer prevention?].

Presse Med 2015 Mar 8;44(3):317-23. Epub 2015 Jan 8.

CHU Lyon Est, hôpital femme mère enfant, département de gynécologie-obstétrique, université Claude-Bernard Lyon 1, 69000 Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2014.07.024DOI Listing
March 2015

Prostate cancer: The main risk and protective factors-Epigenetic modifications.

Ann Endocrinol (Paris) 2015 Feb 13;76(1):25-41. Epub 2015 Jan 13.

Département d'oncogénétique, CBRV, centre Jean-Perrin, 28, place Henri-Dunant, BP 38, 63001 Clermont-Ferrand, France; ERTICA, EA4677, université d'Auvergne, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ando.2014.09.001DOI Listing
February 2015

Mini-P-gp and P-gp Co-Expression in Brown Trout Erythrocytes: A Prospective Blood Biomarker of Aquatic Pollution.

Diagnostics (Basel) 2015 Jan 12;5(1):10-26. Epub 2015 Jan 12.

ERTICa-EA 4677, Département Génie Biologique, Institut Universitaire de Technologie, Clermont Université-Université d'Auvergne, Ensemble universitaire des Cézeaux, B.P. 86-63172 Aubiere, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/diagnostics5010010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665547PMC
January 2015